What Is the Curative Potential of Refractory Leukemia with Related and Unrelated Allogeneic Transplants?
Matt E Kalaycio
Abstract
Matt E Kalaycio
Abstract
Acute leukemia was uniformly fatal until the development of effective therapeutic chemotherapy (CT) regimens in the early 1970s. Combination CT for acute leukemia induced complete remission (CR) in the majority of patients, but postremission therapy was inadequate to prevent relapse (1) . Relapsed patients, and those who failed to achieve CR, invariably died from their leukemia. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Acute leukemia was uniformly fatal until the development of effective therapeutic chemotherapy (CT) regimens in the early 1970s. Combination CT for acute leukemia induced complete remission (CR) in the majority of patients, but postremission therapy was inadequate to prevent relapse (1) . Relapsed patients, and those who failed to achieve CR, invariably died from their leukemia. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Key concepts: Refractory (planetary science), Medicine, Leukemia, Complete remission, Acute leukemia, Oncology, Chemotherapy, Internal medicine